(Q44473260)

3 December 2017

title

Interactions of gamma-hydroxy butyrate with ethanol and NCS 382. (English)

1 reference

3 December 2017

Richard J Lamb

1

1 reference

3 December 2017

Jaclyn Munn

2

1 reference

3 December 2017

Nicklaus J Duiker

3

1 reference

3 December 2017

Andrew Coop

4

1 reference

3 December 2017

Huifang Wu

5

1 reference

3 December 2017

Wouter Koek

6

1 reference

3 December 2017

Charles P France

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

European Journal of Pharmacology

3 December 2017

published in

1 reference

3 December 2017

volume

470

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

157-162

1 reference

Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Cross-tolerance to ethanol and gamma-hydroxybutyric acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Blockade of the discriminative stimulus effects of gamma-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Gamma-hydroxybutyric acid decreases thalamic sensory excitatory postsynaptic potentials by an action on presynaptic GABAB receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gamma-hydroxybutyrate in the rat substantia nigra and striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Effects of concentration of ethanol injected intraperitoneally on taste aversion, body temperature, and activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

ynergy of ethanol and a natural soporific--gamma hydroxybutyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

In vivo conversion of gamma-aminobutyric acid and 1,4-butanediol to gamma-hydroxybutyric acid in rat brain. Studies using stable isotopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

The role of glutamatergic neurotransmission in the pathophysiology of alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901791-6

10.1016/S0014-2999(03)01791-6

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference